Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0031 Transporter Info
Gene Name SLCO2B1
Transporter Name Organic anion transporting polypeptide 2B1
Gene ID
11309
UniProt ID
O94956
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Bifidobacterium

     Bifidobacterium animalis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO2B1 substrates/drugs in the health condition [1]

Detailed Description

 The Bifidobacterium animalis subsp. lactis Bi-07 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO2B1, thereby affecting the efficacy, safety, or bioavailability of the drug.

     Bifidobacterium longum 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO2B1 substrates/drugs in the health condition [1]

Detailed Description

 The Bifidobacterium longum subsp. infantis has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO2B1, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacillota

   Genus: Enterocloster

     Enterocloster bolteae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO2B1 substrates/drugs in the health condition [1]

Detailed Description

 The Enterocloster bolteae WAL 16351 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO2B1, thereby affecting the efficacy, safety, or bioavailability of the drug.

   Genus: Lacrimispora

     Lacrimispora saccharolytica 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO2B1 substrates/drugs in the health condition [1]

Detailed Description

 The Lacrimispora saccharolytica WM1 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO2B1, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacteroidota

   Genus: Bacteroides

     Bacteroides uniformis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO2B1 substrates/drugs in the health condition [1]

Detailed Description

 The Bacteroides uniformis CL03T00C23 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO2B1, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLCO2B1 expression in health condition [2] , [3]

Studied Phenotype

 Health [ICD11: N.A]

Studied Tissue

 Intestine

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Escherichia coli Nissle 1917 has been reported to increase the expression of the drug transporter SLCO2B1.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 13 Microbe Influence Related to This Species      

       Microbe Influence 1

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
1,7-Diamino-8-naphthol-3,6-disulphonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 1,7-diamino-8-naphthol-3,6-disulphonic acid generated from the metabolism of d&c red no.33 by the host unspecified microbiota has been reported to reduce the ability of D&C Red No.33 to inhibit drug transporters SLCO2B1.

       Microbe Influence 2

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
1-Amino-2-naphthol-6-sulfonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 1-amino-2-naphthol-6-sulfonic acid generated from the metabolism of fd&c red no.40 by the host unspecified microbiota has been reported to reduce the ability of FD&C Red No.40 to inhibit drug transporters SLCO2B1.

       Microbe Influence 3

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
1-Amino-2-naphthol-6-sulfonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 1-amino-2-naphthol-6-sulfonic acid generated from the metabolism of fd&c yellow no.6 by the host unspecified microbiota has been reported to reduce the ability of FD&C Yellow No.6 to inhibit drug transporters SLCO2B1.

       Microbe Influence 4

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
2,4-Diaminoresorcinol

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 2,4-diaminoresorcinol generated from the metabolism of d&c brown no.1 by the host unspecified microbiota has been reported to reduce the ability of D&C Brown No.1 to inhibit drug transporters SLCO2B1.

       Microbe Influence 5

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
2-Amino-5-methylbenzenesulfonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 2-amino-5-methylbenzenesulfonic acid generated from the metabolism of d&c red no.6 by the host unspecified microbiota has been reported to reduce the ability of D&C Red No.6 to inhibit drug transporters SLCO2B1.

       Microbe Influence 6

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
4-Amino-3-hydroxy-2-naphthoic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 4-amino-3-hydroxy-2-naphthoic acid generated from the metabolism of d&c red no.6 by the host unspecified microbiota has been reported to reduce the ability of D&C Red No.6 to inhibit drug transporters SLCO2B1.

       Microbe Influence 7

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
4-Amino-5-methoxy-2-methylbenzenesulfonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 4-amino-5-methoxy-2-methylbenzenesulfonic acid generated from the metabolism of fd&c red no.40 by the host unspecified microbiota has been reported to reduce the ability of FD&C Red No.40 to inhibit drug transporters SLCO2B1.

       Microbe Influence 8

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
4-Nitroaniline

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 4-nitroaniline generated from the metabolism of naphthol blue black by the host unspecified microbiota has been reported to reduce the ability of Naphthol Blue Black to inhibit drug transporters SLCO2B1.

       Microbe Influence 9

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
5-Amino-2,4-dimethylbenzenesulfonic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite 5-amino-2,4-dimethylbenzenesulfonic acid generated from the metabolism of fd&c red no.4 by the host unspecified microbiota has been reported to reduce the ability of FD&C Red No.4 to inhibit drug transporters SLCO2B1.

       Microbe Influence 10

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
Aniline

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite aniline generated from the metabolism of d&c red no.33 by the host unspecified microbiota has been reported to reduce the ability of D&C Red No.33 to inhibit drug transporters SLCO2B1.

       Microbe Influence 11

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
Aniline

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite aniline generated from the metabolism of naphthol blue black by the host unspecified microbiota has been reported to reduce the ability of Naphthol Blue Black to inhibit drug transporters SLCO2B1.

       Microbe Influence 12

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
Sulfanilic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite sulfanilic acid generated from the metabolism of d&c brown no.1 by the host unspecified microbiota has been reported to reduce the ability of D&C Brown No.1 to inhibit drug transporters SLCO2B1.

       Microbe Influence 13

 Attenuated inhibition function of SLCO2B1 in conventional mice compared with germ-free mice [4]

Regulating Factor
Sulfanilic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 BALB/c germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite sulfanilic acid generated from the metabolism of fd&c yellow no.6 by the host unspecified microbiota has been reported to reduce the ability of FD&C Yellow No.6 to inhibit drug transporters SLCO2B1.
References
1 Bioaccumulation of therapeutic drugs by human gut bacteria. Nature. 2021 Sep;597(7877):533-538.
2 The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021 Jul;11(7):1789-1812.
3 Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PLoS One. 2014 Feb 5;9(2):e87150.
4 Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):16009-16018.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.